Center for Scientific Review; Notice of Closed Meetings, 85225-85226 [2024-24878]

Download as PDF Federal Register / Vol. 89, No. 207 / Friday, October 25, 2024 / Notices Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Lauren Susan Penney, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 496–1968, penneyls@ csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS). Dated: October 21, 2024. David W. Freeman, Supervisory Program Analyst, Office of Federal Advisory Committee Policy. National Institutes of Health BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Neurological Disorders and Stroke; Notice of Closed Meeting ddrumheller on DSK120RN23PROD with NOTICES1 Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The cooperative agreement applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel; BPN Small Molecule and Biologic Therapeutic Drug Discovery for Disorders of the Nervous System. Date: November 19–20, 2024. Time: 10 a.m. to 2 p.m. Agenda: To review and evaluate cooperative agreement applications. Address: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852. Meeting Format: Virtual Meeting. Contact Person: Eric S. Tucker, Ph.D., Scientific Review Officer, Scientific Review Branch, Division of Extramural Activities, NINDS/NIH/DHHS, 6001 Executive Boulevard, Rockville, MD 20852, 301–827– 0799, eric.tucker@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research 17:40 Oct 24, 2024 Jkt 265001 [FR Doc. 2024–24881 Filed 10–24–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Center for Advancing Translational Sciences; Notice of Closed Meeting [FR Doc. 2024–24877 Filed 10–24–24; 8:45 am] VerDate Sep<11>2014 Dated: October 22, 2024. David W. Freeman, Supervisory Program Analyst, Office of Federal Advisory Committee Policy. Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Advancing Translational Sciences Special Emphasis Panel; NCATS CTSA Training Grants Review Meeting. Date: January 16–17, 2025. Time: 10:00 a.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Address: National Center for Advancing Translational Sciences, National Institutes of Health, 9609 Medical Center Drive, Bethesda, MD 20892 (Video Assisted Meeting). Contact Person: Nakia C. Brown, Ph.D., Scientific Review Officer, Office of Grants Management and Scientific Review, National Center for Advancing Translational Sciences, National Institutes of Health, 9609 Medical Center Drive, Room 1E504, Bethesda, MD 20892, (301) 827–4905, brownnac@ mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.350, B—Cooperative Agreements; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) Dated: October 21, 2024. David W. Freeman, Supervisory Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–24885 Filed 10–24–24; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00090 Fmt 4703 Sfmt 4703 85225 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Fellowships: Epidemiology and Population Sciences. Date: November 14–15, 2024. Time: 9 a.m. to 8 p.m. Agenda: To review and evaluate grant applications. Address: St. Gregory Hotel, 2033 M Street NW, Washington, DC 20036. Meeting Format: In Person. Contact Person: Rebecca I. Tinker, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20817, (301) 435–0637, tinkerri@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR–24– 202: Lasker Clinical Research Scholars Program. Date: November 15, 2024. Time: 9 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Yue Wu, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 803C, Bethesda, MD 20892, (301) 867–5309, wuy25@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Neurotechnology and Neuroengineering. Date: November 15, 2024. Time: 9 a.m. to 4 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Cibu Paul Thomas, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of E:\FR\FM\25OCN1.SGM 25OCN1 ddrumheller on DSK120RN23PROD with NOTICES1 85226 Federal Register / Vol. 89, No. 207 / Friday, October 25, 2024 / Notices Health, 6701 Rockledge Drive, Room 1011–H, Bethesda, MD 20894, (301) 402–4341, thomascp@mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Study In Cancer Biology Area Review. Date: November 15, 2024. Time: 11 a.m. to 8 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Charles Morrow, MD, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6202, MSC 7804, Bethesda, MD 20892, 301–408– 9850, morrowcs@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; AREA/ REAP: Respiratory, Cardiac and Circulatory Sciences. Date: November 15, 2024. Time: 1 p.m. to 7 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Kirk E. Dineley, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institute of Health, 6701 Rockledge Drive, Room 806E, Bethesda, MD 20892, (301) 867–5309, dineleyke@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: The Cancer Biotherapeutics Development (CBD). Date: November 18–19, 2024. Time: 9 a.m. to 7 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Laurie Ann Shuman Moss, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 867–5309, laurie.shumanmoss@ nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Clinical Data Management and Analysis/Clinical Informatics and Digital Health Special Emphasis Panel. Date: November 18–19, 2024. Time: 9 a.m. to 8 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Amy Kathleen Wernimont, BS, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6198, Bethesda, MD 20892, 301–827–6427, amy.wernimont@nih.gov. VerDate Sep<11>2014 17:40 Oct 24, 2024 Jkt 265001 Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR Panel: Metabolic, Cerebrovascular, Environmental, and Sleep Factors in Alzheimer’s Disease and Related Dementias (ADRD). Date: November 18–19, 2024. Time: 9 a.m. to 6:30 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Jennifer Kielczewski, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 435–1042, jennifer.kielczewski@ nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: The Cancer Drug Development and Therapeutics (CDDT). Date: November 18–19, 2024. Time: 9 a.m. to 8 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Lilia Topol, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6192, MSC 7804, Bethesda, MD 20892, 301–451– 0131, ltopol@mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR–22– 180: Maximizing Investigators’ Research Award. Date: November 18, 2024. Time: 9:30 a.m. to 8 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Mollie Kim Manier, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594–0510, mollie.manier@ nih.gov. Name of Committee: Risk, Prevention and Health Behavior Integrated Review Group; HIV/AIDS Intra- and Inter-personal Determinants and Behavioral Interventions Study Section. Date: November 18–19, 2024. Time: 10 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Mark P. Rubert, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5218, MSC 7852, Bethesda, MD 20892, 301–806– 6596, rubertm@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; PO 00000 Frm 00091 Fmt 4703 Sfmt 9990 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: October 21, 2024. David W. Freeman, Supervisory Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–24878 Filed 10–24–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Center for Substance Abuse Prevention Drug Testing Advisory Board; Notice of Availability of Report of Fiscal Year 2023 Closed or Partially Closed Meetings Substance Abuse and Mental Health Services Administration, HHS. AGENCY: ACTION: Notice. A report summarizing the closed or partially closed meeting activities of the SAMHSA’s Center for Substance Abuse Prevention Drug Testing Advisory Board during fiscal year 2023 has been prepared. A copy of this report has been filed with the Library of Congress. SUMMARY: Applicable Date: This notice is applicable October 21, 2024. DATES: The report is available by contacting the DTAB designated federal official, Lisa Davis. ADDRESSES: FOR FURTHER INFORMATION CONTACT: Lisa Davis, Lisa.Davis@samhsa.hhs.gov. Phone: (240) 276–1440. There is a Departmental requirement to complete and submit an Annual Report on Federal advisory committees when an entire or portion of the meeting is closed to the public as required by Section 10(d) of the Federal Advisory Committee Act (FACA). Copies of these reports for FY 2023 are being submitted to the Library of Congress, FACA Desk for public inspection and use. SUPPLEMENTARY INFORMATION: Dated: October 21, 2024. Carlos Castillo, Committee Management Officer, SAMHSA. [FR Doc. 2024–24834 Filed 10–24–24; 8:45 am] BILLING CODE 4162–20–P E:\FR\FM\25OCN1.SGM 25OCN1

Agencies

[Federal Register Volume 89, Number 207 (Friday, October 25, 2024)]
[Notices]
[Pages 85225-85226]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-24878]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Fellowships: Epidemiology and Population Sciences.
    Date: November 14-15, 2024.
    Time: 9 a.m. to 8 p.m.
    Agenda: To review and evaluate grant applications.
    Address: St. Gregory Hotel, 2033 M Street NW, Washington, DC 
20036.
    Meeting Format: In Person.
    Contact Person: Rebecca I. Tinker, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20817, (301) 435-0637, 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR-24-202: Lasker Clinical Research Scholars Program.
    Date: November 15, 2024.
    Time: 9 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Yue Wu, Ph.D., Scientific Review Officer, Center 
for Scientific Review, National Institutes of Health, 6701 Rockledge 
Drive, Room 803C, Bethesda, MD 20892, (301) 867-5309, 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Neurotechnology and Neuroengineering.
    Date: November 15, 2024.
    Time: 9 a.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Cibu Paul Thomas, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of

[[Page 85226]]

Health, 6701 Rockledge Drive, Room 1011-H, Bethesda, MD 20894, (301) 
402-4341, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Study In Cancer Biology Area Review.
    Date: November 15, 2024.
    Time: 11 a.m. to 8 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Charles Morrow, MD, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6202, MSC 7804, Bethesda, MD 
20892, 301-408-9850, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; AREA/REAP: Respiratory, Cardiac and Circulatory Sciences.
    Date: November 15, 2024.
    Time: 1 p.m. to 7 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Kirk E. Dineley, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institute of Health, 
6701 Rockledge Drive, Room 806E, Bethesda, MD 20892, (301) 867-5309, 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Small Business: The Cancer Biotherapeutics Development (CBD).
    Date: November 18-19, 2024.
    Time: 9 a.m. to 7 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Laurie Ann Shuman Moss, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 867-5309, 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Clinical Data Management and Analysis/Clinical Informatics 
and Digital Health Special Emphasis Panel.
    Date: November 18-19, 2024.
    Time: 9 a.m. to 8 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Amy Kathleen Wernimont, BS, Ph.D., Scientific 
Review Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6198, Bethesda, MD 20892, 301-
827-6427, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR Panel: Metabolic, Cerebrovascular, Environmental, and 
Sleep Factors in Alzheimer's Disease and Related Dementias (ADRD).
    Date: November 18-19, 2024.
    Time: 9 a.m. to 6:30 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Jennifer Kielczewski, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 435-1042, 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Small Business: The Cancer Drug Development and Therapeutics 
(CDDT).
    Date: November 18-19, 2024.
    Time: 9 a.m. to 8 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Lilia Topol, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 6192, MSC 7804, Bethesda, MD 20892, 301-451-
0131, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR-22-180: Maximizing Investigators' Research Award.
    Date: November 18, 2024.
    Time: 9:30 a.m. to 8 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Mollie Kim Manier, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-0510, 
[email protected].

    Name of Committee: Risk, Prevention and Health Behavior 
Integrated Review Group; HIV/AIDS Intra- and Inter-personal 
Determinants and Behavioral Interventions Study Section.
    Date: November 18-19, 2024.
    Time: 10 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Mark P. Rubert, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5218, MSC 7852, Bethesda, MD 
20892, 301-806-6596, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: October 21, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee 
Policy.
[FR Doc. 2024-24878 Filed 10-24-24; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.